Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 26, 2018
[ Wed, Sep 26th 2018
] - WOPRAI
Tue, September 25, 2018
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
[ Tue, Sep 25th 2018
] - WOPRAI
Mon, September 24, 2018
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
[ Mon, Sep 24th 2018
] - WOPRAI
Jayson Bedford Maintained (ABT) at Buy with Increased Target to $77 on, Sep 24th, 2018
Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $72 to $77 on, Sep 24th, 2018.
Jayson has made no other calls on ABT in the last 4 months.
There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Jayson's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jayson
- Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $72 on, Thursday, July 19th, 2018
Similar Stocks and Investing Articles
[ Thu, Jan 25th 2018
] - WOPRAI
[ Tue, May 26th 2015
] - WOPRAI
[ Fri, Jan 30th 2015
] - WOPRAI
[ Wed, Oct 29th 2014
] - WOPRAI
[ Tue, Sep 02nd 2014
] - WOPRAI
[ Thu, Jul 17th 2014
] - WOPRAI
[ Fri, Feb 15th 2013
] - WOPRAI
[ Thu, Feb 14th 2013
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI